Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]

Hodgkins - update on treatment strategies in children and adolescents

Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany

Hodgkins - update on treatment strategies in children and adolescents ( Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany )

Use of novel agents in childhood ALL

Prof Lia Gore - Children's Hospital Colarado, Aurora, USA

Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi

Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )

Radiotherapy in Hogkin lymphoma: reducing risk in later life

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Radiotherapy in Hogkin lymphoma: reducing risk in later life ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )

Entrectinib, a novel treatment for TRK fusions, shows early promise against a...

Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA

Entrectinib, a novel treatment for TRK fusions, shows early promise against a range of cancer types ( Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA )

First outcome results from MINDACT breast cancer clinical trial

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium

First outcome results from MINDACT breast cancer clinical trial ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

Genetics may influence risk for breast cancer after chest radiotherapy to treat...

Dr Lindsay Morton - National Cancer Institute, Bethesda, USA

Genetics may influence risk for breast cancer after chest radiotherapy to treat childhood cancer ( Dr Lindsay Morton - National Cancer Institute, Bethesda, USA )

A presurgery combination therapy may improve outcomes for women with Her2...

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania...

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )

5 year survival rates for nivolumab-treated metastatic melanoma patients much...

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )

CD4 T-cell immunotherapy targeting MAGE-A3 is safe, and shows early clinical...

Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA

CD4 T-cell immunotherapy targeting MAGE-A3 is safe, and shows early clinical responses ( Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA )

New investigational targeted therapeutic, entrectinib, shows early promise

Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA

New investigational targeted therapeutic, entrectinib, shows early promise ( Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA )

More from ecancer